Entries of Engel, J. B. on the publication server
![]() | Up a level |
Number of items: 4.
2015
Kwok, C. W., Treeck, O., Buchholz, S., Seitz, S., Ortmann, O. and Engel, J. B.
(2015)
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).
Targeted Oncology 10 (3), pp. 365-373.
Fulltext not available.
(2015)
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).
Targeted Oncology 10 (3), pp. 365-373.
Fulltext not available.
2012
Engel, J. B.
, Seipelt, I., Hönig, A., Hahne, J. C. and Teifel, M.
(2012)
AEZS-131- ein hochselektiver ERK-Inhibitor: Charakterisierung und präklinische Testung im tripelnegativen Mammakarzinom (TNBC).
Geburtshilfe und Frauenheilkunde 72 (07).
Fulltext not available.
, Seipelt, I., Hönig, A., Hahne, J. C. and Teifel, M.
(2012)
AEZS-131- ein hochselektiver ERK-Inhibitor: Charakterisierung und präklinische Testung im tripelnegativen Mammakarzinom (TNBC).
Geburtshilfe und Frauenheilkunde 72 (07).
Fulltext not available.
Hahne, J. C., Honig, A., Meyer, S. R., Gambaryan, S.
, Walter, U.
, Wischhusen, J., Häussler, S. F. M., Segerer, S. E., Fujita, N., Dietl, J. and Engel, J. B.
(2012)
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
Oncology Reports 28 (6), pp. 2023-2028.
Fulltext not available.
, Walter, U.
, Wischhusen, J., Häussler, S. F. M., Segerer, S. E., Fujita, N., Dietl, J. and Engel, J. B.
(2012)
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
Oncology Reports 28 (6), pp. 2023-2028.
Fulltext not available.
Engel, J. B.
, Schally, A. V.
, Buchholz, S., Seitz, S., Emons, G. and Ortmann, O.
(2012)
Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).
Archives of Gynecology and Obstetrics 286 (2), pp. 437-442.
Fulltext not available.
, Schally, A. V.
, Buchholz, S., Seitz, S., Emons, G. and Ortmann, O.
(2012)
Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).
Archives of Gynecology and Obstetrics 286 (2), pp. 437-442.
Fulltext not available.
